Showing results (201-210 of 611) with videos related to

Sort By:
Pageof 62
Expert Opinion on Biological Therapy|February 13, 2018
Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of 'real-world' evidenceJonathan A Bernstein, Abhishek Kavati, Michael D Tharp, et al.
Annals of Medicine and Surgery (2012)|January 18, 2022
Contact dermatitis due to personal protective equipment use and hygiene practices during the COVID-19 pandemic: A systematic review of case reportsZouina Sarfraz, Azza Sarfraz, Muzna Sarfraz, et al.
American Journal of Rhinology & Allergy|October 8, 2009
Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitisJonathan A Bernstein, Bruce Prenner, Berrylin J Ferguson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 16, 2020
A novel functional C1 inhibitor activity assay in dried blood spot for diagnosis of Hereditary angioedemaYongquan Lai, Guodong Zhang, Zhiwei Zhou, et al.
Allergy and Asthma Proceedings|May 17, 2013
Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedemaCheng Gang, Christopher J Lindsell, Joseph Moellman, et al.
Dermatology and Therapy|September 30, 2023
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current StatusThomas B Casale, Ana Maria Gimenez-Arnau, Jonathan A Bernstein, et al.
International Archives of Allergy and Immunology|August 9, 2017
A Pilot Study Investigating Clinical Responses and Biological Pathways of Azelastine/Fluticasone in Nonallergic Vasomotor Rhinitis before and after Cold Dry Air ProvocationUmesh Singh, Jonathan A Bernstein, Holly Lorentz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 13, 2009
Is exhaled nitric oxide a useful adjunctive test for assessing asthma?Jonathan A Bernstein, Ben Davis, María J Alvarez-Puebla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 21, 2024
Patient-Reported Outcome Measures in Chronic Spontaneous Urticaria, Angioedema, and Atopic DermatitisJonathan A Bernstein, Chistian Apfelbacher, Derek K Chu, et al.
Current Medical Research and Opinion|May 13, 2024
Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice surveyArpamas Seetasith, Michael Holden, James Hetherington, et al.
Pageof 62